Author

J. D. Wolf

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 3 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Organism:mouse· 1 Organism:non-human primate· 1 Organism:rat· 1 Approach:statistical model· 1

Frequent Co-Authors

A. L. Greninger· 3 shared C. M. Lieber· 3 shared M. G. Natchus· 3 shared R. Cox· 3 shared R. K. Plemper· 3 shared A. Kolykhalov· 2 shared G. R. Painter· 2 shared K. Sakamoto· 2 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

A. L. Greninger

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Therapeutic mitigation of measles-like immune amnesia and exacerbated disease after prior respiratory virus infections in ferrets

R. K. Plemper, R. Cox, J. D. Wolf, N. A. P. Lieberman, C. M. Lieber, H.-J. Kang, Z. M. Sticher, J.-J. Yoon, M. K. Andrews, M. Govindarajan, R. E. Krueger, E. B. Sobolik, M. G. Natchus, A. Gewirtz, R. deSwart, , A. L. Greninger

This study shows that prior respiratory virus infections worsen measles severity in ferrets and that antiviral treatment can mitigate immune amnesia and disease outcomes regardless of treatment timing.

bioRxiv · Sep 1, 2023Microbiology

Paxlovid-like nirmatrelvir/ritonavir fails to block SARS-CoV-2 transmission in ferrets

R. Cox, C. M. Lieber, J. D. Wolf, A. Karimi, N. A. P. Lieberman, Z. M. Sticher, P. Roychoudhury, M. K. Andrews, R. E. Krueger, M. G. Natchus, G. R. Painter, A. Kolykhalov, A. L. Greninger, R. K. Plemper

This study compares the efficacy of paxlovid and molnupiravir in preventing SARS-CoV-2 transmission in ferrets, finding that molnupiravir reduces transmission while paxlovid does not.

bioRxiv · Nov 20, 2022 · PreprintMicrobiology

SARS-CoV-2 variant of concern type and biological sex affect efficacy of molnupiravir in dwarf hamster model of severe COVID-19

C. M. Lieber, R. Cox, J. Sourimant, J. D. Wolf, K. Juergens, Q. Phung, M. T. Saindane, M. G. Natchus, G. R. Painter, K. Sakamoto, A. L. Greninger, R. K. Plemper

This study evaluates molnupiravir efficacy against SARS-CoV-2 variants in different models, finding VOC-dependent efficacy and sex-based differences in dwarf hamsters.

bioRxiv · Feb 4, 2022 · PreprintMicrobiology